Small-scale potential IVDS operates with 11-50 employees and is focused on point-of-care diagnostics, dry chemistry and microfluidics. This presents opportunities for partnerships or contract development to scale early-stage products and explore co-development of affordable POCT devices for healthcare, veterinary, and consumer markets.

POCT focus The company specializes in portable and affordable Point-of-Care devices and rapid whole blood separation, indicating a strong fit for sales outreach around rapid diagnostics solutions, test strip and meter integration, and colorimetric assays for bedside or field use.

R&D leverage With 25+ years in formulation chemistry, blood separation, and analytical methods, IVDS could benefit from collaborations on new assay development, stability testing, and independent testing protocols to accelerate commercialization of novel diagnostic tests.

Licensing and IP Having six U.S. patents and multiple licensing agreements suggests mutual value in exploring co-development, technology licensing, or strategic partnerships to expand product lines and access larger distribution channels.

Growth readiness Revenue in the 1–10 million range places IVDS as an attractive target for tiered enterprise collaborations, pilot programs with larger distributors, and potential scale-up partnerships with mid-market players seeking to enhance their POCT portfolio.